Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

New Delhi Metallo-β-Lactamase-5 (NDM-5)-Producing Klebsiella pneumoniae Urinary Tract Infection in a Young Patient Without a History of Overseas Travel: A Case Suggesting Local Spread in Japan.

Created on 28 Sep 2026

Authors

Nao Nishimiura, Hideyuki Hayashi, Makoto Kuroda, Tatsuya Kawaguchi, Hirotomo Nakata, Jun-Ichirou Yasunaga

Published in

Cureus. Volume 18. Issue 8. Pages e115335. Epub Aug 28, 2026.

Abstract

We isolated New Delhi metallo-β-lactamase-5 (NDM-5)-producing Klebsiella pneumoniae KU-00156 from a young individual with no history of overseas travel or exposure to foreign healthcare facilities. During hematologic recovery after chemotherapy for osteosarcoma, the patient developed a urinary tract infection. Urine cultures yielded Klebsiella pneumoniae and Enterococcus faecalis. The K. pneumoniae isolate demonstrated resistance to multiple β-lactam antibiotics, including carbapenems, and PCR-based carbapenemase gene testing confirmed the presence of NDM. Whole-genome analysis revealed that the strain KU-00156 was an NDM-5-producing K. pneumoniae ST290, harboring multiple resistance genes, including bla NDM-5, on an IncHI2-replicon type plasmid. This case represents the detection of NDM-5-producing K. pneumoniae from a young individual without a history of overseas exposure and is considered an important case suggesting the possible prevalence of NDM-5 in the Japanese community.

PMID:
42802794
Bibliographic data and abstract were imported from PubMed on 28 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 9
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement